Norethindrone Acetate Tablet
Product Images NDC 50742-267

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Norethindrone Acetate (NDC 50742-267). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure001)

Pharmacokinetic concentration-time curve for Norethindrone acetate tablets 5 mg, showing plasma concentration (ng/mL) on the vertical axis versus time (hours) on the horizontal axis over a 36-hour period. The graph illustrates absorption, peak concentration, and elimination phases following oral administration.*

FDA Label Image

50's Count Container Label (Noreth 5mg 50s V1)

Label for Norethindrone Acetate Tablets, USP 5 mg by Ingenus Pharmaceuticals, LLC. The label states the medication is an orally active progestin in a 50 tablet count container. It includes storage instructions to keep the product at 20° to 25°C, dispensing warnings, a barcode, and serialization space. The label is marked Rx only and manufactured for Ingenus Pharmaceuticals, Orlando, FL.*

FDA Label Image

Structure (Structure)

Chemical structure of norethindrone acetate, depicting its molecular framework with labeled carbon chains and chemical bonds characteristic of this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.